1208 Evidence on Access to and Use of Medicines to Treat Chronic Diseases from Household Surveys in Five Low and Middle Income Countries
Authors: Brian Serumaga (1), Dennis Ross- Degnan (2), Maryam Bigdeli (3), Robert LeCates (2), Anita Wagner (2), Catherine Vialle-Valentin (2) 1.Division of Primary Care, School of Community Health Sciences, University Of Nottingham Medical School, UK 2.Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Healthcare Institute, USA 3.Alliance for Health Policy and Systems Research, World Health Organization, Switzerland
What is the problem? Evidence about treatment of chronic diseases in the community is lacking in most low and middle income countries.
Design Descriptive secondary analysis of cross-sectional of survey data Low income countries: Ghana, Kenya, and Uganda Middle income countries: Jordan, Philippines 2007 and 2009
Predictors of access to medicines for chronic diseases at household level Socioeconomic status : 0.61 (0.44 to 0.85, p=0.004) Insurance coverage : 2.22 (1.98 to 2.93, p=0.017) Others Household could not afford medicines Have a member of the household who earns > 1hr from a public health facility
Thank you
Predictors of access to medicines for chronic diseases at household level Predictorodds ratiolowerupperP>|z| Socioeconomic status (poor vs non-poor) located in capital or commercial region Jordan Ghana Kenya Uganda > 1hr from free public health facility > 1hr from private health facility reported multiple chronic illnesses medicines partly/wholly covered by insurance have member of household who earns total cost of chronic disease medicines (dollars)